Research about a birth control pill for emergency contraception

Primary Objective

Are you interested in how your body works, specifically regarding ovulation?

Is this Study for You?

Let's Get Started!

Description

To research how a single dose of an oral contraceptive pill, Drospirenone, affects ovulation (the process of egg release from the ovary).

Main Procedures Involved: Participation will last up to 6 weeks and consist of visits around the time of ovulation. Participation will include taking a single dose of the oral contraceptive, Drospirenone. Participants will come to clinic for transvaginal ultrasounds and blood draws every other day around the time of ovulation and then daily for up to 7 days following administration of Drospirenone.

Duration of Participation: Last up to 6 weeks

Details
Age

18 to 35 years

Compensation

300

Principal Investigator
Photograph of Paige Kendall, MD

Paige Kendall, MD

Resources
Study ID

Protocol Number: 22-2178

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers